Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
331.00
-7.48 (-2.21%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Cencora Revenue
Cencora had revenue of $84.75B in the quarter ending June 30, 2026, with 5.07% growth. This brings the company's total for the last twelve months to $332.77B, up 5.09% year-over-year. In the fiscal year ending September 30, 2025, Cencora had annual revenue of $321.33B with 9.31% growth. That makes Cencora the 14th largest company in the world by revenue and 9th in the United States.
Revenue (ttm)
$332.77B
Revenue Growth
+5.09%
P/S Ratio
0.19
Revenue / Employee
$6,524,928
Employees
51,000
Market Cap
63.16B
Revenue by Segment
- US Human Health 285.29B 88.8%
- International Alliance Healthcare 24.39B 7.6%
- Other Healthcare Solutions 5.97B 1.9%
- US Animal Health 5.69B 1.8%
Fiscal year ended Sep 30, 2025 See the full Cencora breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 321.33B | 27.37B | 9.31% |
| Sep 30, 2024 | 293.96B | 31.79B | 12.12% |
| Sep 30, 2023 | 262.17B | 23.59B | 9.89% |
| Sep 30, 2022 | 238.59B | 24.60B | 11.50% |
| Sep 30, 2021 | 213.99B | 24.09B | 12.69% |
| Sep 30, 2020 | 189.89B | 10.30B | 5.74% |
| Sep 30, 2019 | 179.59B | 11.65B | 6.94% |
| Sep 30, 2018 | 167.94B | 14.80B | 9.66% |
| Sep 30, 2017 | 153.14B | 6.29B | 4.29% |
| Sep 30, 2016 | 146.85B | 10.89B | 8.01% |
| Sep 30, 2015 | 135.96B | 16.39B | 13.71% |
| Sep 30, 2014 | 119.57B | 31.61B | 35.94% |
| Sep 30, 2013 | 87.96B | 9.88B | 12.65% |
| Sep 30, 2012 | 78.08B | -614.85M | -0.78% |
| Sep 30, 2011 | 78.70B | 919.20M | 1.18% |
| Sep 30, 2010 | 77.78B | 6.02B | 8.38% |
| Sep 30, 2009 | 71.76B | 1.57B | 2.24% |
| Sep 30, 2008 | 70.19B | 8.92B | 14.56% |
| Sep 30, 2007 | 61.27B | 454.37M | 0.75% |
| Sep 30, 2006 | 60.81B | 10.80B | 21.59% |
| Sep 30, 2005 | 50.01B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| McKesson | 410.98B |
| Cardinal Health | 254.25B |
| Henry Schein | 13.60B |
| Accendra Health | 2.65B |
| 111, Inc. | 1.54B |
| EDAP TMS | 79.31M |
| Cosmos Health | 73.73M |
| Akso Health Group | 13.83M |
COR News
- 2 days ago - Cencora price target raised to $345 from $330 at BofA - TheFly
- 2 days ago - Cencora sees FY26 adjusted EPS to be at least $17.90 - TheFly
- 3 days ago - Cencora price target raised to $375 from $373 at Baird - TheFly
- 3 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Passage Bio, Inc. (Nasdaq – PASG), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE – UTZ), Finward Bancorp (Nasdaq – FNWD) - GlobeNewsWire
- 3 days ago - Cencora to acquire American Oncology Network in $2.4B transaction - TheFly
- 3 days ago - Cencora to acquire American Oncology Network in $2.4 billion deal - Reuters
- 4 days ago - Cencora to Acquire American Oncology Network to Strengthen Support of Community Oncology - Business Wire
- 4 days ago - Cencora price target raised to $380 from $340 at Argus - TheFly